Norero B, Pérez-Ayuso RM, Duarte I, Ramirez P, Soza A, Arrese M, Benítez C

Idioma: Ingles.
Referencias bibliográficas: 32
Paginas: 142-149
Archivo PDF: 118.81 Kb.

RESUMEN

Sin resuemn.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010; 17: 101-4.

2. Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2009; 6: 608-17.

3. Buck FS, Koss MN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 1991; 22: 904-7.

4. Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 1988; 85: 73-80.

5. Itescu S. Hepatic amyloidosis. An unusual cause of ascites and portal hypertension. Arch Intern Med 1984; 144: 2257-9.

6. Koklu S, Odemis B, Cengiz C, Yuksel O, Uskudar O, Turhan N. Fulminant hepatic failure due to secondary amyloidosis. Dig Liver Dis 2006; 38: 208-10.

7. Basile G, Villari D, Nicita-Mauro V. Giant hepatomegaly and portal hypertension in an elderly patient with primary liver amyloidosis: an uncommon clinical occurrence. Eur Rev Med Pharmacol Sci 2000; 4(1-2): 47-50.

8. Tabata S, Kurata M, Takeda J, Funayama Y, Yamauchi N, Aoki K, Kato A, et al.Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma. Rinsho Ketsueki 2012; 53(11): 1906-10.

9. Rajkumar SV. Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011; 86: 57-65.

10. Petre S, Shah IA, Gilani N. Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy. Aliment Pharmacol Ther 2008; 27: 1006-16.

11. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 2003; 82: 291-8.

12. Christou L, Economou M, Economou G, Kolettis TM, Tsianos EV. Characteristics of ascitic fluid in cardiac ascites. Scand J Gastroenterol 2007; 42: 1102-5.

13. Bion E, Brenard R, Pariente EA, Lebrec D, Degott C, Maitre F, Benhamou JP. Sinusoidal portal hypertension in hepatic amyloidosis. Gut 1991; 32: 227-30.

14. Aramaki T, Terada H, Okumura H, Tsutsui H, Fujita S, Tajiri T, Ohya T, et al. Portal hypertension secondary to intrahepatic arterio-portal shunt in primary amyloidosis: a case report. Gastroenterol Jpn 1989; 24(4): 410-3.

15. Gavilan JC, Bermudez FJ, Marquez A, Sanchez-Carrillo JJ, Gonzalez-Santos P. Hepatic amyloidosis as cause of severe intrahepatic cholestasis. An Med Interna 2003; 20: 25-7.

16. Güllü BE, Hatemý I, Ozbay G, Tüzüner N, Sonsuz A. A rare case of primary systemic amyloidosis presenting with hepatic failure. Turk J Gastroenterol 2011; 22(1): 113-4.

17. Kumar KS, Lefkowitch J, Russo MW, Hesdorffer C, Kinkhabwala M, Kapur S, Emond JC, et al. Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. Gastroenterology 2002; 122: 2026-31.

18. Hung HH, Huang DF, Tzeng CH, Su CH, Su TP, Chen HC, Tsay SH, et al. Systemic amyloidosis manifesting as a rare cause of hepatic failure. J Chin Med Assoc 2010; 73(3): 161-5.

19. Ales NC, Daniels JT, Frizell ER, Koff JM, Kaplan KJ, Wortmann GW. Multiple myeloma-associated amyloidosis manifesting as fulminant hepatic failure. South Med J 2001; 94: 1036-8.

20. Giers K, Niemczyk S, Ziarkiewicz-Wroblewska B, Matuszkiewicz- Rowinska J. A rare cause of acute hepatic failure. Liver Int 2008; 28(9): 1249.

21. Ferreira S, Baldaia C, Fatela N, Ramalho F, Costa MA, Brito D, Esteves G, Monteiro E. Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis. Scand J Gastroenterol 2008; 43(3): 375-9.

22. Kobayashi T, Sato Y, Ichida T, Ito S, Yamamoto S, Oya H, Sato D, et al. Primary amyloidosis with liver failure and acute renal failure treated with emergency living-related liver transplantation: a case report. Transplant Proc 2003; 35: 356-7.

23. Ubiña Aznar E, Fernández Moreno N, Rivera Irigoín R, Moreno Mejías P, Fernández Pérez F, Vera Rivero F, Navarro Jarabo JM, et al. Massive hepatic amyloidosis with fatal hepatic failure. Rev Esp Enferm Dig 2006; 98(7): 551-2.

24. Sandberg-Gertzen H, Ericzon BG, Blomberg B. Primary amyloidosis with spontaneous splenic rupture, cholestasis, and liver failure treated with emergency liver transplantation. Am J Gastroenterol 1998; 93: 2254-6.

25. Varela M, De Las Heras D, Miquel R. Hepatic failure due to primary AL amyloidosis. J Hepatol 2003; 39: 290.

26. McDonald P, Usbourne C, Playfer JR. A case of intrahepatic cholestasis due to amyloidosis. Int J Clin Pract 1998; 52(3): 201-2.

27. Casiraghi MA, De Paoli A, Assi A, Palladini G, Lavazza MT, Beretta A, Gualdoni G, et al. Hepatic amyloidosis with light chain deposition disease. A rare association. Dig Liver Dis 2000; 32: 795-8.

28. Nowak G, Westermark P, Wernerson A, Herlenius G, Sletten K, Ericzon BG. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int 2000; 13: 92-7.

29. Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012; 55: 965-7.

30. Wang YD, Zhao CY, Yin HZ. Primary hepatic amyloidosis: a mini literature review and five cases report. Ann Hepatol 2012; 11: 721-7.

31. Gertz MA. How to manage primary amyloidosis. Leukemia 2012; 26: 191-8.

32. Gertz MA, Lacy MQ, Dispenzieri A, Kumar SK, Buadi FK, Dingli D, Leung N, et al. Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006. Bone Marrow Transplant 2011; 46: 970-5.